autologous gene-modified PD-1-positive T lymphocytes Sc610
Term · Oncology and biomedicine · MLC-T-ONC-011631
A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous gene-modified PD-1-positive T lymphocytes Sc610 bind to tumor cells expressing the antigen for the as of yet undisclosed receptor, which may result in specific cytotoxic T-lymphocyte (CTL)-mediated tumor cell killing.
| Identifier | MLC-T-ONC-011631 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous gene-modified PD-1-positive T cells Sc610 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011631",
"term": "autologous gene-modified PD-1-positive T lymphocytes Sc610",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous gene-modified PD-1-positive T lymphocytes Sc610 bind to tumor cells expressing the antigen for the as of yet undisclosed receptor, which may result in specific cytotoxic T-lymphocyte (CTL)-mediated tumor cell killing.",
"synonyms": [
"autologous gene-modified PD-1-positive T cells Sc610"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-gene-modified-pd-1-positive-t-lymphocytes-sc610/"
}
Record 2,966 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.